• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BJOG . Pregnancy and risk of COVID-19: a Norwegian registry-linkage study

tetano

Editor, Senior Moderator
BJOG


. 2021 Oct 17.
doi: 10.1111/1471-0528.16969. Online ahead of print.
Pregnancy and risk of COVID-19: a Norwegian registry-linkage study


Maria C Magnus[SUP] 1 2 [/SUP], Laura Oakley[SUP] 1 3 [/SUP], Håkon K Gjessing[SUP] 1 4 [/SUP], Olof Stephansson[SUP] 5 6 [/SUP], Hilde M Engjom[SUP] 7 8 [/SUP], Ferenc Macsali[SUP] 7 8 [/SUP], Petur B Juliusson[SUP] 7 9 [/SUP], Anne-Marie Nybo Andersen[SUP] 10 [/SUP], Siri E Håberg[SUP] 1 [/SUP]



Affiliations

Abstract

Objective: To compare the risk of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and contact with specialist health-care services for coronavirus disease 2019 (COVID-19) between pregnant and non-pregnant women.
Population or sample: All women ages 15 to 45 living in Norway on March 1[SUP]st[/SUP] , 2020 (N=1,033,699).
Methods: We linked information from the national birth, patient, communicable diseases, and education databases using unique national identifiers.
Main outcome measure: We estimated hazard ratios (HR) among pregnant compared to non-pregnant women of having a positive test for SARS-CoV-2, a diagnosis of COVID-19 in specialist healthcare, or hospitalization with COVID-19 using Cox regression. Multivariable analyses adjusted for age, marital status, education, income, country of birth and underlying medical conditions.
Results: Pregnant women were not more likely to be tested for or to a have a positive SARS-CoV-2 test (adjusted HR, 0.99; 95% confidence interval [CI]: 0.92-1.07). Pregnant women had higher risk of hospitalization with COVID-19 (HR, 4.70; 95% CI: 3.51- 6.30), and any type of specialist care for COVID-19 (HR, 3.46; 95% CI: 2.89-4.14). Pregnant women born outside Scandinavia were less likely to be tested, and at higher risk of a positive test (HR, 2.37; 95% CI: 2.51-8.87). Compared to pregnant Scandinavian born women, pregnant women with minority background had a higher risk of hospitalization with COVID-19 (HR, 4.72; 95% CI: 2.51-8.87).
Conclusion: Pregnant women were not more likely to be infected with SARS-CoV-2. Still, pregnant women with COVID-19, especially those born outside of Scandinavia, were more likely to be hospitalized.

Keywords: COVID-19; SARS-CoV-2; pregnancy.
 
Back
Top Bottom